Equities

Fonar Corp

Fonar Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)16.31
  • Today's Change0.05 / 0.31%
  • Shares traded11.32k
  • 1 Year change+3.69%
  • Beta1.2187
Data delayed at least 15 minutes, as of May 03 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

FONAR Corporation is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging scanners, MRI, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. The Company conducts its business in two segments. The medical equipment segment is conducted directly through FONAR. The physician management and diagnostic services segment is conducted through its subsidiary Health Management Corporation of America (HMCA). HMCA provides management services, administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing, information technology (IT) services, hiring, conducting interviews and managing personnel, storage of medical records, office space, equipment, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging.

  • Revenue in USD (TTM)102.42m
  • Net income in USD12.16m
  • Incorporated1978
  • Employees561.00
  • Location
    Fonar Corp110 Marcus DrMELVILLE 11747-4228United StatesUSA
  • Phone+1 (631) 694-2929
  • Fax+1 (631) 753-5150
  • Websitehttp://www.fonar.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Asensus Surgical Inc8.58m-78.43m65.55m207.00--1.91--7.64-0.3162-0.31620.03440.12610.0981.702.9841,434.78-89.57-71.10-103.14-79.04-53.38-71.39-914.46-1,207.712.31--0.00--21.02-18.67-3.80---6.14--
Alpha Pro Tech, Ltd.61.23m4.19m71.18m124.0017.191.1313.921.160.35430.35435.165.390.91691.7211.25493,814.506.2715.216.5216.0637.2840.236.8412.9312.83--0.000.00-1.215.6027.642.935.50--
Monogram Orthopaedics Inc365.00k-13.75m73.53m28.00------201.46-0.4621-0.46210.0123--0.0241----13,035.71-90.82-119.26-149.39-257.400.00---3,765.81-5,045.60----0.00-------0.3964---15.97--
Vivos Inc19.50k-2.89m77.46m10.00--56.85--3,972.43-0.0079-0.00790.000050.00350.0116--2.17---172.67-202.25-191.32-552.77-30.9710.79-14,844.92-11,969.07----0.00---46.58---17.19------
Vuzix Corp12.13m-50.15m84.79m94.00--1.05--6.99-0.7893-0.78930.19121.250.1111.463.10129,033.50-45.91-41.61-50.66-44.80-21.72-6.13-413.46-317.286.23--0.00--2.488.42-23.02--39.42--
Envoy Medical Inc316.00k-29.91m85.26m34.00------269.81-2.60-2.600.0207-0.0899------9,294.12---------149.68---9,464.56--0.8169-266.25----33.33---87.83------
Vivani Medical Inc0.00-25.65m97.86m44.00--4.38-----0.5042-0.50420.000.40680.00----0.00-52.93-56.58-60.80-67.66-------2,868.72----0.00-------84.69--40.33--
KORU Medical Systems Inc29.32m-13.27m106.05m82.00--5.55--3.62-0.2905-0.29050.64220.41810.89192.386.85357,595.80-40.35-17.60-47.06-20.2960.2459.44-45.24-21.703.37--0.0284--2.2310.44-58.65--11.10--
Myomo Inc19.24m-8.15m108.29m101.00--11.35--5.63-0.2726-0.27260.62650.33131.563.788.99190,506.40-65.86-81.78-104.03-115.2768.5168.50-42.34-85.762.16--0.00--23.7051.0924.00--2.82--
Fonar Corp102.42m12.16m109.44m561.009.350.66795.271.071.741.7414.6024.420.512420.351.44182,570.608.338.738.649.6045.6748.3316.2516.399.15--0.0055--1.083.89-24.71-15.058.48--
Xtant Medical Holdings Inc91.30m660.00k110.68m207.00--2.1528.871.21-0.0042-0.00420.7550.39451.191.325.78441,072.500.8636-10.381.15-14.6860.7561.080.7229-8.661.22-4.020.2997--57.504.81107.78--18.47--
Neuronetics Inc71.35m-30.19m114.20m203.00--3.24--1.60-1.06-1.062.491.180.61322.094.86351,468.00-25.95-28.02-33.60-34.7375.1375.73-42.31-51.044.33-5.280.6342--9.426.2218.76--18.57--
Akso Health Group - ADR2.20m-17.07m114.41m12.00------51.94-0.7466-0.24610.0963--0.11661.910.3202183,560.00-89.84-17.36-224.28-23.997.56---770.59-256.641.36-24.020.6531--119.69-34.25-221.68------
TELA Bio Inc58.45m-46.66m116.37m227.00--6.12--1.99-2.06-2.062.560.77080.80131.477.15257,502.20-63.97-52.00-80.09-60.9568.6265.32-79.83-107.653.45-8.440.6821--41.1347.85-5.35---17.12--
Delcath Systems Inc2.07m-47.68m141.44m76.00--8.02--68.50-2.98-2.980.12730.69310.07310.23876.8027,171.05-168.85-116.57-377.02-243.2169.2571.02-2,308.86-1,235.372.06-26.530.3915---24.05-9.53-30.60---5.26--
Data as of May 03 2024. Currency figures normalised to Fonar Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.